US 12,251,251 B2
Radiation capsule for bowel disease imaging and localize drug delivery
Yoav Kimchy, Haifa (IL); and Alex Ovadia, Haifa (IL)
Assigned to CHECK-CAP LTD., Isfiya (IL)
Appl. No. 17/776,232
Filed by CHECK-CAP LTD., Isfiya (IL)
PCT Filed Jan. 5, 2021, PCT No. PCT/IL2021/050012
§ 371(c)(1), (2) Date May 12, 2022,
PCT Pub. No. WO2021/140504, PCT Pub. Date Jul. 15, 2021.
Claims priority of provisional application 62/957,335, filed on Jan. 6, 2020.
Prior Publication US 2022/0395242 A1, Dec. 15, 2022
Int. Cl. A61B 6/40 (2024.01); A61B 6/00 (2024.01); A61B 6/06 (2006.01); A61B 6/42 (2024.01)
CPC A61B 6/4057 (2013.01) [A61B 6/06 (2013.01); A61B 6/425 (2013.01); A61B 6/4258 (2013.01); A61B 6/4266 (2013.01); A61B 6/485 (2013.01); A61B 6/547 (2013.01)] 19 Claims
OG exemplary drawing
 
1. An imaging capsule, comprising:
a radiation source;
a collimator that provides a collimated beam from the radiation source;
at least one detector configured to detect particles resulting from X-ray fluorescence and/or Compton backscattering in response to the collimated beam to reconstruct images of a user's gastrointestinal tract;
wherein the imaging capsule is configured to identify whether a specific area is an inflamed area, within the user's gastrointestinal tract, based on a count of the detected particles resulting from the Compton backscattering and initiate actions responsive to detecting the inflamed area.